首页> 外文OA文献 >1557. Population Pharmacokinetics of Suvratoxumab (MEDI4893), an Extended Half-life Staphylococcus aureus Alpha Toxin-Neutralizing Human Monoclonal Antibody, in Healthy Adults and Patients on Mechanical Ventilation in Intensive Care Units

【2h】

1557. Population Pharmacokinetics of Suvratoxumab (MEDI4893), an Extended Half-life Staphylococcus aureus Alpha Toxin-Neutralizing Human Monoclonal Antibody, in Healthy Adults and Patients on Mechanical Ventilation in Intensive Care Units

机译：1557. Suvratoxumab（Medi4893）的人口药代动力学，延长半衰期的葡萄球菌α毒素中和人单克隆抗体，在健康的成人和患者中进行了重症监护单位的机械通气

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Vadryn Pierre; Bruno Francois; Martha Hernandez-Illas; Miguel Sánchez Garcia; Yuling Wu; Philippe Eggimann; Pierre-Francois Laterre; Vincent Huberlant; Lucia Viña; Thierry Boulain; Alexey Ruzin; Cédric Bretonnière; Jerome Pugin; José Trenado Álvarez; Terramika Bellamy; Kathryn Shoemaker; Omar Ali; Nancy Lee; Pierre-Francois Dequin; Hasan S Jafri; Lorin Roskos; Susan Colbert; Anis Khan;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults [J] . Yu Xiang-Qing, Robbie Gabriel J., Wu Yuling, Antimicrobial agents and chemotherapy. . 2017,第1期

机译：Medi4893的安全性，耐受性和药代动力学，研究，延长半衰期，抗葡萄球菌，抗金黄色葡萄球菌α-毒素人类单克隆抗体，在健康的成年人中
2. Characterisation of anti‐alpha toxin antibody levels and colonisation status after administration of an investigational human monoclonal antibody, MEDI4893, against Staphylococcus aureus alpha toxin [J] . Alexey Ruzin, Yuling Wu, Li Yu, Clinical & translational immunology. . 2018,第1期

机译：给予抗金黄色葡萄球菌α毒素的研究性人类单克隆抗体MEDI4893后，抗α毒素抗体水平和定居状态的表征
3. Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893 [J] . Tabor David E., Yu Li, Mok Hoyin, Antimicrobial agents and chemotherapy. . 2016,第9期

机译：金黄色葡萄球菌α-毒素在全球监测研究中收集的多种医院呼吸分离物中是保守的，并通过单克隆抗体Medi4893中和
4. Mining patient data from heterogeneous sources for decision making on administration of non invasive mechanical ventilation in intensive care units [C] . Garcia Maria N.Moreno, Gonzalez Felix Martin, Robledo Javier Gonzalez, International Conference on Information Fusion . 2014

机译：从异构源中挖掘患者数据，以制定重症监护病房无创机械通气的管理决策
5. 1557. Population Pharmacokinetics of Suvratoxumab (MEDI4893) an Extended Half-life Staphylococcus aureus Alpha Toxin-Neutralizing Human Monoclonal Antibody in Healthy Adults and Patients on Mechanical Ventilation in Intensive Care Units [O] . Vadryn Pierre, Bruno Francois, Martha Hernandez-Illas, -1

机译：1557. Suvratoxumab（MEDI4893）（一种延长的半衰期金黄色葡萄球菌α-毒素中和性人类单克隆抗体）在健康成人和重症监护病房中进行机械通气的患者的群体药代动力学
6. Faculty Opinions recommendation of Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults. [O] . Fernando Polack 2019

机译：教师观点建议Medi8897的安全性，耐受性和药代动力学，呼吸道合胞病毒预防F靶向单克隆抗体，延长半衰期，在健康的成年人中。

1557. Population Pharmacokinetics of Suvratoxumab (MEDI4893), an Extended Half-life Staphylococcus aureus Alpha Toxin-Neutralizing Human Monoclonal Antibody, in Healthy Adults and Patients on Mechanical Ventilation in Intensive Care Units

著录项

引文网络

相似文献

相关主题

期刊订阅